0001209191-13-037018.txt : 20130717
0001209191-13-037018.hdr.sgml : 20130717
20130717164000
ACCESSION NUMBER: 0001209191-13-037018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130715
FILED AS OF DATE: 20130717
DATE AS OF CHANGE: 20130717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stamoulis Christiana
CENTRAL INDEX KEY: 0001502917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13972937
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-07-15
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001502917
Stamoulis Christiana
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Corp Strategy & Bus Devlp
Common Stock
2013-07-15
4
M
0
1125
33.82
A
41837
D
Common Stock
2013-07-15
4
S
0
1025
86.25
D
40812
D
Common Stock
2013-07-15
4
S
0
100
87.33
D
40712
D
Common Stock
939
I
401(k)
Stock Option
33.82
2013-07-15
4
M
0
1125
0.00
D
2020-07-13
Common Stock
1125
4500
D
Transaction made pursuant to Ms. Stamoulis' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $86.25 (range $85.96 to $86.55).
Ms. Stamoulis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
The option vests in 16 quarterly installments from 07/14/2010.
Kenneth L. Horton, Attorney-In-Fact
2013-07-17